Back to Search
CHRISTOPHER PITTENGER, M.D., PH.D.
Psychiatry Physician
NPI: 1235318478Individual
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
043577(CT)
Research & Publications (20)
Stress, depression, and neuroplasticity: a convergence of mechanisms.
PMID 17851537·Neuropsychopharmacology·2008
6-review
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.
PMID 16490414·NeuroRx·2006
6-review
Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
PMID 19577308·J Affect Disord·2010
4-observational
Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder.
PMID 19468281·Mol Psychiatry·2010
1-meta
Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review.
PMID 18186076·Am J Med Genet B Neuropsychiatr Genet·2008
1-meta
A double dissociation revealing bidirectional competition between striatum and hippocampus during learning.
PMID 18955704·Proc Natl Acad Sci U S A·2008
7-preclinical
Meta-analysis of the symptom structure of obsessive-compulsive disorder.
PMID 18923068·Am J Psychiatry·2008
1-meta
Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology.
PMID 18516051·Nat Med·2008
7-preclinical
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up.
PMID 18480706·J Clin Psychopharmacol·2008
8-other
Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania.
PMID 17284151·J Clin Psychiatry·2007
5-case
Gabapentin abuse, and delirium tremens upon gabapentin withdrawal.
PMID 17388722·J Clin Psychiatry·2007
5-case
The NMDA receptor as a therapeutic target in major depressive disorder.
PMID 17430148·CNS Neurol Disord Drug Targets·2007
6-review
Systematic review: pharmacological and behavioral treatment for trichotillomania.
PMID 17727824·Biol Psychiatry·2007
4-observational
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.
PMID 16374600·Psychopharmacology (Berl)·2006
5-case
Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors.
PMID 17110840·J Clin Psychopharmacol·2006
5-case
Visual hallucinations from the addition of riluzole to memantine and bupropion.
PMID 16633160·J Clin Psychopharmacol·2006
5-case
Impaired bidirectional synaptic plasticity and procedural memory formation in striatum-specific cAMP response element-binding protein-deficient mice.
PMID 16525060·J Neurosci·2006
4-observational
Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder.
PMID 16420092·J Clin Psychiatry·2005
5-case
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
PMID 15993857·Biol Psychiatry·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 34 PARK ST, 3RD FLOOR, CNRU
NEW HAVEN, CT 06519 - Phone
- (203) 974-7560
Quick Facts
- NPI
- 1235318478
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile